Just In
- 4 hrs ago
4 DIY Hair Masks For Monsoon Season, To Manage Hair Fall And Dandruff
- 6 hrs ago
Hadid Sisters Hit Runway For Marc Jacobs With Partially 'Shaved' Heads And Bleached Brows
- 7 hrs ago
July 2022: Lucky And Unlucky Zodiac Signs This Month
- 7 hrs ago
Expert Article: Pericoronitis, An Unfamiliar But Agonizing Dental Issue
Don't Miss
- Finance
BoB Capital Suggests Buy This Mid Cap Consumer Electricals Stock For 43% Potential Upside
- News
Prez polls: Draupadi Murmu seeks support in Puducherry
- Sports
WWE Friday Night Smackdown results, recap and highlights: July 1, 2022
- Movies
Is it Ajith Vs Vijay For Pongal 2023? Fans Of Both The Actors Await With Bated Breath!
- Education
IDBI Executive Call Letter 2022 Released For Online Examination, Download IDBI Bank Executive Admit Card
- Automobiles
2022 TVS iQube - Can It Compete With The Best Now?
- Technology
Xiaomi 12S Series To Get Eco-Friendly Leather Rear Panel; Expected Features, Specs
- Travel
Best Day Trips From Mumbai To Take Now
Decision On Which Vaccine To Be Given As Precautionary Dose Expected Soon: Govt
There have been extensive deliberations on whether the precautionary (third) dose of Covid vaccine for healthcare and frontline workers and citizens above 60 years with comorbidities should be the same as the first two doses and a decision is expected soon, the government said on Thursday.
Addressing a press conference, ICMR Director-General Dr Balram Bhargava said the government will issue clear cut recommendations on this before January 10, when administering of the precautionary dose to healthcare and frontline workers and those above 60 years with comorbidities will begin.
"We are having an extensive debate (on which vaccine to be given as a precautionary dose). We've had a series of meetings in NTAGI (National Technical Advisory Group on Immunisation) yesterday, the day before and today.
"We are deciding what is the population that will require this vaccine which includes frontline workers, healthcare workers and 60 plus with comorbidities. What are new vaccines available and which vaccine can be given in terms of safety and in terms of efficacy," Bhargava said.
"So, we are analysing all the data that is available in terms of which vaccine can be given...whether it is going to be the same one or it is going to be a different one. Before January 10 we will have to clear cut recommendations on the same. The drug controller and the NTAGI are meeting and that decision will be taken," he said.
According to the 'Guidelines for COVID-19 vaccination of children between 15-18 years and precaution dose to healthcare and frontline workers and 60 years + population with comorbidities' issued by the health ministry, prioritisation and sequencing of the "precaution dose" for them would be based on completion of nine months from the date of administration of the second dose, which is 39 weeks.
They will be able to access vaccination for the precaution dose through their existing Co-WIN account, the guidelines which will come into effect from January 3 stated.
Eligibility for the precaution dose will be based on the date of administration of the second dose as recorded in the Co-WIN system, which will send an SMS for availing the precaution dose when it becomes due, the guidelines stated.
- wellnessNTAGI To Review Covaxin Corbevax Data For 6-12 Years Thursday, Discuss Reducing Booster Dose Gap
- wellnessEven Vaccinated People Can Develop Long Covid, Study Finds
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- basicsNovavax's Covid-19 Vaccine Covovax Gets Emergency Use Authorisation For 12-17 Age Group In India
- wellnessAIIMS Delhi To Start Booster Dose Trial Of Intranasal Covid Vaccine From March 11
- wellnessDecision On COVID-19 Vaccine Precaution Dose For All Adults Will Be Based On Scientific Need: Govt
- healthIsrael To Administer Fourth Dose Of COVID-19 Vaccine For Medical Personnel And Senior Citizens
- healthHospital Launches Vaccination Programme For Children Aged 15-18 Yrs Across The Country
- healthSII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
- healthIndia-US Healthcare Collaboration In Spotlight As India Approves Two More Covid-19 Vaccines
- healthCovovax Better Booster For Covishield-Vaccinated People: Dr Shahid Jameel, Virologist
- wellnessCovovax: Everything You Need To Know About The Novavax COVID-19 Vaccine Approved For India